… salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group …
HAM Kerstjens, TB Casale, ER Bleecker… - The Lancet …, 2015 - thelancet.com
… Addition of tiotropium (delivered via the dry-powder HandiHaler device [Boehringer Ingelheim,
Ingelheim am Rhein, Germany]) to beclomethasone (two puffs of 40 μg twice daily) was …
Ingelheim am Rhein, Germany]) to beclomethasone (two puffs of 40 μg twice daily) was …
[HTML][HTML] Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study
…, C Amos, R Owen, C Lassen, INSIST Study Group - Respiratory …, 2011 - Elsevier
… This 12-week randomised, parallel-group study compared the efficacy of indacaterol 150
μg once-daily to salmeterol 50 μg twice-daily in patients with moderate-to-severe COPD. …
μg once-daily to salmeterol 50 μg twice-daily in patients with moderate-to-severe COPD. …
A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group
MG Britton, JS Earnshaw… - European Respiratory …, 1992 - Eur Respiratory Soc
… salmeterol treatment compared to salbutamol treatment subgroups. The results of the study
clearly demonstrate that salmeterol, … -blind, double dummy, parallel-group design throughout …
clearly demonstrate that salmeterol, … -blind, double dummy, parallel-group design throughout …
… with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study
CF Vogelmeier, ED Bateman, J Pallante… - The Lancet …, 2013 - thelancet.com
… study compares a dual bronchodilator (QVA149; a once-daily, … LABA and ICS (salmeterol–fluticasone
[SFC]; twice a day), in … Our study hopes to address the question of whether, in a …
[SFC]; twice a day), in … Our study hopes to address the question of whether, in a …
… of salmeterol/fluticasone propionate versus montelukast in childhood asthma: a prospective, randomized, double-blind, double-dummy, parallel-group study
J Maspero, F Guerra, F Cuevas, JP Gutierrez… - Clinical …, 2008 - Elsevier
… during treatment with ICS plus salmeterol versus ICS alone (66 studies [N = 20,966], of which
6 were in pediatrics [n = 1575]) concluded that salmeterol combined with ICS significantly …
6 were in pediatrics [n = 1575]) concluded that salmeterol combined with ICS significantly …
… with moderate to severe reversible obstructive airways disease—a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 μg) with salmeterol …
…, GL Shepherd, K Viskum, International study group - Respiratory …, 1992 - Elsevier
… This study shows that salmeterol at both dose levels, 50 ltg and 100/tg twice daily, is an
effective … The study was double-blind parallel-grouped and randomized in design, comparing …
effective … The study was double-blind parallel-grouped and randomized in design, comparing …
… efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone propionate, and …
A Lindqvist, EM Karjalainen, LA Laitinen, T Kava… - Journal of allergy and …, 2003 - Elsevier
… , double-blind, double-dummy, parallel group study to compare the effects of 16 weeks of
treatment with either salmeterol (… The aim was to quantify the within-group treatment effects as …
treatment with either salmeterol (… The aim was to quantify the within-group treatment effects as …
Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients
A Grove, BJ Lipworth - The Lancet, 1995 - thelancet.com
… The purpose of the present study was therefore to evaluate the … salbutamol after regular
exposure to twice daily salmeterol. … Compared with placebo, salmeterol produced a parallel right …
exposure to twice daily salmeterol. … Compared with placebo, salmeterol produced a parallel right …
… once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a …
…, P Day, C Frenzel, N Kurstjens, Glisten Study Group - Thorax, 2015 - thorax.bmj.com
… This was a multicentre, blinded, placebo-controlled parallel group 12-week study. After a
pre-… take SAL/FP twice daily and had salbutamol to use as rescue medication during the study. …
pre-… take SAL/FP twice daily and had salbutamol to use as rescue medication during the study. …
Salmeterol compared with slow‐release terbutaline in nocturnal asthma A multicenter, randomized, double‐blind, double‐dummy, sequential clinical trial
…, D Georges, L Bertin, French Multicenter Study Group… - Allergy, 1994 - Wiley Online Library
… , double-blind, double-dummy, parallel-group clinical trial with a … This study confirms
that salmeterol, 50 fig twice daily, is … with the control group, twice as many salmeterol-treated …
that salmeterol, 50 fig twice daily, is … with the control group, twice as many salmeterol-treated …
相关搜索
- randomised double blind parallel group study
- twice daily salmeterol bronchodilator subsensitivity
- dual bronchodilator parallel group
- sequential clinical trial double dummy
- twelve month comparison european study group
- study group salmeterol xinafoate
- torch study salmeterol fluticasone
- canadian multicenter study salmeterol and salbutamol
- multicentre study group slow release theophylline
- salmeterol fluticasone in patients glisten study
- inhaled salmeterol dose response study
- salmeterol fluticasone combination randomized study
- double blind salmeterol in nocturnal asthma
- 28 day clinical trial
- influence of salmeterol pilot study
- twice daily salmeterol fluticasone in patients